GenIbet joins iBET as shareholder
01.04.2017Genibet is a CDMO (Contract Development and Manufacturing Organization) created in 2006, with headquarters in Oeiras and that is dedicated to the manufacture of biopharmaceutical products.
iBET was present at the Nutraceuticals Europe Summit & Expo in Madrid
27.02.2017NUTRACEUTICALS Europe Summit & Expo, took place in Madrid (Spain) on the 22nd and 23rd February and gathered the sector of the functional and novel ingredients.
The TYPHIVAC project has been considered as one of the success stories of the EUREKA program
09.02.2017The project was led by GenIbet (www.genibet.com) in partnership with iBET and the Novartis Vaccines Institute for Global Health. Read here the interview with GenIbet's CEO, Raquel Fortunato.
Bernardo Abecasis, PhD student at the Animal Cell Technology Unit (iBET/ITQB NOVA), was awarded with the Best Poster Snapshot Presentation at the Scale-Up and Manufacturing of Cell-based Therapies V
08.02.2017The conference took place at San Diego, California, USA (15-19 January).
Improved tumor cell models are paramount to overcome current shortcomings of pre-clinical research and drug discovery
02.01.2017A perspective view from the team of the Advanced Cell Models Laboratory | Animal Cell Technology Unit of iBET and partners from AbbVie.
Yesterday iBET received the visit of Frank Stangenberg-Haverkamp, Chairman of the Executive Board of Merck KG
04.11.2016During his visit to Portugal, Frank Stangenberg-Haverkamp took the opportunity to visit two research institutes that showcase the high scientific expertise that Portugal has offer: iBET and Fundação Champalimaud.
Daniel Mestre won the best poster presentation prize at the ESACT Frontiers Retreat
02.11.2016The first ESACT Frontiers Retreat took place October 20th – 22nd 2016 in Lyon, France
Daniel Simão, researcher from the Animal Cell Technology Unit (iBET/ITQB NOVA), was awarded with the Best Young Scientist Oral Presentation at the 19th Congress of the European Society of Toxicology in vitro (ESTIV)
26.10.2016The meeting took place in Juan-les-Pins, France (17-20 October 2016)
The European Commission (EC) recently authorized the marketing of LETIFEND®
15.09.2016LETIFEND® was developed by Laboratórios LETI (Spain) and counted with the strong collaboration of iBET and GeniBET in early stage process development and manufacture
The latest edition of iBET's Facts & Figures is now available
23.08.2016Check out iBET's most Recent News: Collaborations; Highlights; Projects; Awards and much more...